CRH Medical Corp (NYSEAMERICAN:CRHM) was the recipient of a significant growth in short interest in November. As of November 30th, there was short interest totalling 1,483,184 shares, a growth of 5.2% from the November 15th total of 1,410,081 shares. Approximately 2.1% of the company’s shares are sold short. Based on an average daily volume of 91,455 shares, the days-to-cover ratio is currently 16.2 days.

Several institutional investors and hedge funds have recently modified their holdings of CRHM. Vanguard Group Inc. bought a new stake in CRH Medical in the second quarter worth approximately $150,000. Bank of Montreal Can increased its holdings in CRH Medical by 128.4% in the second quarter. Bank of Montreal Can now owns 28,700 shares of the company’s stock worth $164,000 after purchasing an additional 16,135 shares in the last quarter. Advisor Group Inc. increased its holdings in CRH Medical by 35.0% in the second quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock worth $206,000 after purchasing an additional 9,389 shares in the last quarter. PDT Partners LLC increased its holdings in CRH Medical by 176.4% in the second quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock worth $285,000 after purchasing an additional 32,013 shares in the last quarter. Finally, TD Asset Management Inc. increased its holdings in CRH Medical by 57.7% in the second quarter. TD Asset Management Inc. now owns 67,203 shares of the company’s stock worth $382,000 after purchasing an additional 24,596 shares in the last quarter.

CRH Medical (CRHM) opened at $2.35 on Friday. CRH Medical has a 1 year low of $1.46 and a 1 year high of $9.25.

A number of brokerages have recently issued reports on CRHM. Zacks Investment Research downgraded CRH Medical from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Morgan Stanley upgraded CRH Medical from an “equal weight” rating to an “overweight” rating in a research report on Friday, November 17th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $7.50.

WARNING: This piece of content was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/crh-medical-corp-crhm-short-interest-up-5-2-in-november/1767133.html.

CRH Medical Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.